The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection (Q90256870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

title

The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

Mycobacterium tuberculosis

1 reference

Musa Marimani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Aijaz Ahmad

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Adriano Duse

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

publication date

30 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

page(s)

200-214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

Tuberculosis: what we don't know can, and does, hurt us.

12 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Heparin-binding hemagglutinin HBHA from Mycobacterium tuberculosis affects actin polymerisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mycobacterium tuberculosis heparin-binding haemagglutinin adhesin (HBHA) triggers receptor-mediated transcytosis without altering the integrity of tight junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Heparin-binding hemagglutinin (HBHA) of Mycobacterium leprae is expressed during infection and enhances bacterial adherence to epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

CD14 is a pattern recognition receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: a comprehensive resource for tuberculosis research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

N-Terminal clustering of the O-glycosylation sites in the Mycobacterium tuberculosis lipoprotein SodC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The role of superoxide dismutase in the survival of Mycobacterium tuberculosis in macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Adaptive immunity to mycobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Bacterial adhesion and entry into host cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Role and contribution of pulmonary CD103+ dendritic cells in the adaptive immune response to Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Modulation of human T cell cytokines by the Mycobacterium tuberculosis-secreted protein Wag31.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mycobacterium tuberculosis Rv1987 induces Th2 immune responses and enhances Mycobacterium smegmatis survival in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

T cells in mycobacterial infection and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Macrophages and control of granulomatous inflammation in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mycobacterium tuberculosis PE25/PPE41 protein complex induces necrosis in macrophages: Role in virulence and disease reactivation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Cholesterol plays a larger role during Mycobacterium tuberculosis in vitro dormancy and reactivation than previously suspected.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Evaluation of rapid GeneXpert MTB/RIF method using DNA tissue specimens of vertebral bones in patients with suspected spondylitis TB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Three year evaluation of Xpert MTB/RIF in a low prevalence tuberculosis setting: A Scottish perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Multidrug-resistant tuberculosis detection and characterization of mutations in mycobacterium tuberculosis by genotype MTBDRplus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

A comparative study between full-dose and half-dose intravesical immune bacille Calmette-Guérin injection in the management of superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The role of BCG in prevention of leprosy: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Causes of variation in BCG vaccine efficacy: examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Airway luminal T cells: a newcomer on the stage of TB vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

How does the level of BCG vaccine protection against tuberculosis fall over time?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Advances in the development of new tuberculosis drugs and treatment regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Acquired resistance of Mycobacterium tuberculosis to bedaquiline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Tuberculosis drug resistance: a global threat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Asymmetric cell division in Mycobacterium tuberculosis and its unique features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Reversible lipid accumulation and associated division arrest of Mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mathematical model of mycobacterium-host interaction describes physiology of persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Muralytic activity of Micrococcus luteus Rpf and its relationship to physiological activity in promoting bacterial growth and resuscitation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The rpf gene of Micrococcus luteus encodes an essential secreted growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Individual Mycobacterium tuberculosis resuscitation-promoting factor homologues are dispensable for growth in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Global expression profiling of strains harbouring null mutations reveals that the five rpf-like genes of Mycobacterium tuberculosis show functional redundancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

A member of the cAMP receptor protein family of transcription regulators in Mycobacterium tuberculosis is required for virulence in mice and controls transcription of the rpfA gene coding for a resuscitation promoting factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Genomic mapping of cAMP receptor protein (CRP Mt) in Mycobacterium tuberculosis: relation to transcriptional start sites and the role of CRPMt as a transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Expression of a subset of heat stress induced genes of mycobacterium tuberculosis is regulated by 3',5'-cyclic AMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mycobacterium tuberculosis cAMP receptor protein (Rv3676) differs from the Escherichia coli paradigm in its cAMP binding and DNA binding properties and transcription activation properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The Mycobacterium tuberculosis Clp gene regulator is required for in vitro reactivation from hypoxia-induced dormancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Transcriptional and Physiological Changes during Mycobacterium tuberculosis Reactivation from Non-replicating Persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Characterization of a Clp protease gene regulator and the reaeration response in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mycobacterium tuberculosis gene expression at different stages of hypoxia-induced dormancy and upon resuscitation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Antimicrobial Resistance in Mycobacterium tuberculosis: The Odd One Out.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Molecular mechanisms of drug resistance in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2'-O-methylations in 16S and 23S rRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Delamanid for multidrug-resistant pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The bacterial and host factors associated with extrapulmonary dissemination of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Effects of dexmedetomidine on the ratio of T helper 1 to T helper 2 cytokines in patients undergoing laparoscopic cholecystectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

T helper-2 cytokine/regulatory T-cell gene polymorphisms and their relation with risk of psoriasis in a South Indian Tamil cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Disseminated tuberculosis in interferon gamma gene-disrupted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Survival of Mycobacterium tuberculosis in Host Macrophages Involves Resistance to Apoptosis Dependent upon Induction of Antiapoptotic Bcl-2 Family Member Mcl-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mannose-binding protein B allele confers protection against tuberculous meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Racial differences in susceptibility to infection by Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Genome scan of M. tuberculosis infection and disease in Ugandans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

IL10 Haplotype Associated with Tuberculin Skin Test Response but Not with Pulmonary TB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Common variants at 11p13 are associated with susceptibility to tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Genetic dissection of immunity to mycobacteria: the human model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Tuberculosis in children and adults: two distinct genetic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Age-dependent association between pulmonary tuberculosis and common TOX variants in the 8q12-13 linkage region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Whole genome analysis of an MDR Beijing/W strain of Mycobacterium tuberculosis with large genomic deletions associated with resistance to isoniazid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Identification of novel loci associated with mycobacterial isoniazid resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

CD4+ T cell polyfunctional profile in HIV-TB coinfection are similar between individuals with latent and active TB infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Interferon-γ release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Preventing and treating biologic-associated opportunistic infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Tuberculosis susceptibility of diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Tuberculosis and diabetes mellitus: convergence of two epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Implications of the global increase of diabetes for tuberculosis control and patient care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Tuberculosis and nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Risk factors for tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Cigarette smoking and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Regulation of mucociliary clearance in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Cigarette smoke increases susceptibility to tuberculosis--evidence from in vivo and in vitro models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Alcohol use as a risk factor for tuberculosis - a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Translating the Histone Code

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Chromatin modifications and their function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Epigenetic and Transcriptomic Regulation of Lung Repair during Recovery from Influenza Infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Manipulation of host-cell pathways by bacterial pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Histone modifications and chromatin remodeling during bacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

DNA demethylation dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Functions of site-specific histone acetylation and deacetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

CpG islands and the regulation of transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Unraveling methylation changes of host macrophages in Mycobacterium tuberculosis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Genes required for mycobacterial growth defined by high density mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Lysine acetylation of the Mycobacterium tuberculosis HU protein modulates its DNA binding and genome organization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The functions of animal microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Genome-wide non-CpG methylation of the host genome during M. tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Discriminating Active Tuberculosis from Latent Tuberculosis Infection by flow cytometric measurement of CD161-expressing T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Immune parameters differentiating active from latent tuberculosis infection in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Multidrug- and extensively drug-resistant tuberculosis, Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

The non-human primate model of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA screen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Decreased infectivity despite unaltered C3 binding by a DeltahbhA mutant of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

Epigenetics: A New Bridge between Nutrition and Health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2018.10.009

10.1016/J.TUBE.2018.10.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30514504%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference